"The results from this landmark study across 37 countries provide strong evidence that semaglutide can help patients with MASH by not only improving liver health, but also addressing the underlying metabolic issues that contribute to the disease," says Arun Sanyal, a professor of medicine at Virginia Commonwealth University
However, these tolerability issues ultimately impeded its regulatory and clinical progression
Weve got a lot of research to do, Yanovski says
By working closely with a healthcare provider and using platforms like Heally for support, patients can ensure their tirzepatide therapy remains safe, effective, and well-aligned with their goals
This groundbreaking treatment has shown significant results in clinical trials, offering a promising solution for those struggling with weight management